|Summary of psychometric qualities|
|Short name of behavioural scale||Items||Sample||% DSH||Reliability||External validity|
|SIQTR-5||A1, B1,C1, D1, E1||84, females, EDTP, av.age 24||30.4%a||α = 0.62c||Common SHI items r = 0.43 - 0.75h|
|SITBI-11||Q150: (1)-(11)||94, 77% females, MHU, av.age 17||68.1%b||Κ =1.0e||FASM, Κ = 1.0e; r = 0.99g|
|ICC = .71g|
|DSHI-16||Q1- Q16||150, 68% females, UG, age range 18 to 64||35%b||Φ = 0.68e, r = 0.92f||MHhx, r= 0.49e; BPO, r = 0.48g; SA r = 0.21g|
|ISAS-12||Q1: (1)-(12)||235 UG (selected from 761 UG), 55% females, av.age 18||30.8%b||r = 0.85g||MSI-BPD, r = 0.37g; YRBS SI item, r = 0.38g; YRBS SA item, r = 0.28g|
|SHI-16||Q1-Q16||290, 52% females, UG, av.age 20||68%b||Φ = 0.94e, r = 0.84f||NR|
|SHI-22||Q1–Q22||221, 90% females, MHU (4) PMC (104), EDTP/SATP (113), age range 17 to 63||71.9%b||α =0.80d†||DIB, r = 0.76f;|
|PDQ-R, r = 0.73f|
EDTP eating disorder treatment program, SATP substance abuse treatment program, UG under-graduates, MHU mental health unit, PMC primary medical care, α Coefficient Alpha, Κ Coefficient Kappa, Φ Coefficient Phi, ICC Intra Class Correlation, MHhx mental health history, SI suicide ideation, SA suicide attempt, NR not reported, MSI-BPD McLean Screening Instrument for Borderline Personality Disorder ; YRBS Youth Risk Behaviours Survey , DIB Diagnostic Interview for Borderlines , PDQ-R Personality Diagnostic Questionnaire Revised , FASM Functional Assessment of Self-Mutilation , BPO Borderline Personality Organization Scale , a one or more DSH behaviours in past month, b one or more DSH behaviours in lifetime, c items scored 0,1 for presence in last month, d items scored 0,1 for presence in lifetime, e dichotomous variable (lifetime presence) scored 0 (no items endorsed) and 1 (at least one item endorsed), f continuous variable (lifetime presence) scored as sum of 0,1 endorsements across all items, g continuous variable (lifetime frequency) scored as sum of frequency across all items, h continuous variable (frequency for each item) in last month, †  (107, 57% females, MHU, aged 18 to 65).
Latimer et al.
Latimer et al. BMC Psychiatry 2013 13:4 doi:10.1186/1471-244X-13-4